16.84CAD+0.90%Mkt Cap: 427.59M CADP/E: 10.21Last update: 2026-06-01
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and r…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap427.59M CAD
Enterprise Value422.60M CAD
Revenue (TTM)50.94M CAD
Gross Profit40.42M CAD
Net Income (TTM)27.33M CAD
Revenue/Share2.010 CAD
Last Price16.84 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)10.21
P/E (Forward)14.64
PEG—
EV/EBITDA15.63
EV/Revenue8.30
P/S8.32
P/B2.34
EPS (TTM)1.64
EPS (Forward)1.14
52W Range
11.9857% of range20.56
52W High20.56 CAD
52W Low11.98 CAD
Profitability
Gross Margin80.12%
Oper. Margin44.74%
EBITDA Margin53.10%
Profit Margin54.17%
ROE21.65%
ROA17.46%
Growth
Revenue Growth4.00%
Earnings Growth140.00%
Cash Flow & Leverage
Operating CF29.73M CAD
CapEx (TTM)201.00K CAD
FCF Margin43.76%
FCF Yield5.21%
Net Debt-5.98M CAD
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.04
Current Ratio1.25
Quick Ratio0.79
Book Value/Sh7.138 CAD
Cash/Share0.2500 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)20.64 CAD
Target Range17.00 CAD – 22.25 CAD
# Analysts4
Ownership
Shares Out.25.39M
Float15.09M
Insiders42.39%
Institutions1.31%
Short Interest
Short Ratio2.2d
Short % Out.0.26%
Shares Short57.17K
Short (prev mo.)69.66K
Technical
SMA 5017.84 (-5.6%)
SMA 20015.68 (+7.4%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)27.47K
Avg Vol (10d)22.94K
Technical Indicators
RSI (14)40.5
MACD-0.3945
MACD Signal-0.2739
MACD Hist.-0.1206
BB Upper19.11 CAD
BB Middle17.44 CAD
BB Lower15.77 CAD
BB Width19.15%
ATR (14)0.6115 CAD
Vol Ratio (20d)0.83x